Eventide Asset Management - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 27 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$6,458,000
-22.6%
1,040,000
-7.1%
0.10%
-25.0%
Q4 2020$8,344,000
+22.9%
1,120,0000.0%0.13%
-3.8%
Q3 2020$6,787,000
-27.4%
1,120,0000.0%0.13%
-34.5%
Q2 2020$9,352,000
+118.7%
1,120,000
+55.6%
0.20%
+46.0%
Q1 2020$4,277,000
-8.3%
720,0000.0%0.14%
+6.1%
Q4 2019$4,666,000
+34.7%
720,0000.0%0.13%
+14.9%
Q3 2019$3,463,000
+20.2%
720,0000.0%0.11%
+29.5%
Q2 2019$2,880,000
-17.5%
720,0000.0%0.09%
-26.7%
Q1 2019$3,492,000
-24.0%
720,0000.0%0.12%
-40.9%
Q4 2018$4,594,000
-24.4%
720,000
-2.9%
0.20%
-9.0%
Q3 2018$6,078,000
-21.5%
741,1750.0%0.22%
-30.5%
Q2 2018$7,738,000
-13.6%
741,1750.0%0.32%
-23.6%
Q1 2018$8,961,000
+21.3%
741,1750.0%0.42%
+9.1%
Q4 2017$7,390,000741,1750.38%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Opaleye Management Inc. 900,000$5,742,0002.14%
Southpoint Capital Advisors LP 3,997,214$25,502,0001.23%
Avoro Capital Advisors LLC 1,105,999$7,056,0000.42%
683 Capital Management, LLC 971,351$6,197,0000.38%
Eventide Asset Management 720,000$4,594,0000.20%
Granahan Investment Management 364,933$2,328,0000.16%
Zebra Capital Management LLC 17,568$112,0000.07%
Hartford Financial Management Inc. 10,000$64,0000.02%
Weiss Multi-Strategy Advisers LLC 25,000$160,0000.01%
MEEDER ASSET MANAGEMENT INC 9,740$62,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders